Concepedia

Francisco Borrego

FB

Statistics

Publications

62

Citations

5K

H-Index

38

Active since

1993

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Ikerbasque

BioCruces Health research Institute

Center for Drug Evaluation and Research

Francisco Borrego is an author at National Institutes of Health specializing in life sciences, immunology, and cell biology.

ORCID

Publications per year

1993–2023

62

Publications

62

Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis

Francisco Borrego, Matthias Ulbrecht, Elisabeth H. Weiss et al. · The Journal of Experimental Medicine · 1998 · 715 citations · Full text

, , +15

NK phenotypic markers and IL2 response in NK cells from elderly people

Francisco Borrego, M. C. Alonso, M.D. Galiani et al. · Experimental Gerontology · 1999 · 279 citations

, , +14

NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor

Andrëw G. Brööks, Phillip E. Posch, Christopher J. Scorzelli et al. · The Journal of Experimental Medicine · 1997 · 259 citations · Full text

, , +14

CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor

Francisco Borrego, Robertson, RITZ et al. · Immunology · 1999 · 245 citations · Full text

, , +11

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma

R. Angelo de Claro, Karen M. McGinn, Virginia E. Kwitkowski et al. · Clinical Cancer Research · 2012 · 209 citations

, , +17

1–5 of 62